Table 2.
Laboratory values at presentation and after treatment
| Patient lab values | Normal range | ||
|---|---|---|---|
| At admission | After 5 weeks of antiretroviral therapy | ||
| Hemoglobin, g/L | 159 | 117 | 137–180 |
| White blood cell, ×109/L | 3.0 | 3.2 | 4.0–11.0 |
| Platelets, ×109/L | 50 | 207 | 150–400 |
| Sodium, mmol/L | 139 | 139 | 133–145 |
| Potassium, mmol/L | 3.4 | 4.0 | 3.3–5.1 |
| Chloride, mmol/L | 107 | 108 | 98–111 |
| Bicarbonate, mmol/L | 16 | 24 | 21–31 |
| Creatinine, μmol/L | 160 | 97 | 50–120 |
| Total bilirubin, μmol/L | 20 | 11 | 0–24 |
| Haptoglobin, g/L | 1.24 | 0.30–2.00 | |
| Lactate Dehydrogenase (LDH), U/L | 1739 | 242 | 100–235 |
| Ferritin, μg/L | 69,717 | 30–400 | |
| D-dimer, mg/L | >10 | <0.46 | |
| Fibrinogen, g/L | 2.0 | 1.6–4.1 | |
| Creatine kinase, U/L | 25,000 | 232 | 0–195 |
| Triglycerides, mmol/L | 4.36 | 0.60–2.30 | |
| CD4 Count, ×109/L | 0.137 | 0.275 | 0.499–1.651 |
| Viral load, copies/mL | >7.24 log base 10 | 1.96 log base 10 | |
| HIV Architect 4th generation assay | 615.18 | 27.3 | <1 |
| Western blot | Negative | Negative | |